Company Financials

ANI Pharmaceuticals, Inc. Financials

United States dollar

business ANI Pharmaceuticals, Inc. Company Profile

Main Stock Listing

NASDAQ: ANIP

Market Capitalization $1.76 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 49.02
Forward PE 9.20
Price to Sales TTM $2.13
Price to Book MRQ $3.24
Enterprise to Revenue 2.42
Enterprise to EBITDA 13.78

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 4.91%
Operating Margin 10.20%
Return on Assets TTM 2.49%
Return on Equity TTM 8.66%

Income Statement

Revenue TTM $826,880,000
Revenue per Share TTM $41.89
Quarterly Revenue Growth 53.60%
Gross Profit TTM $502,335,008
EBITDA $144,542,000
Net Income to Common TTM $34,148,000
Diluted EPS TTM $1.60
Quarterly Earnings Growth YoY 53.58%

Balance Sheet

Total Cash MRQ $271,468,992
Total Cash per Share MRQ $12.99
Total Debt MRQ $
Total Debt to Equity MRQ 124.86
Current Ratio MRQ 2.58
Book Value per Share MRQ $24.19

Cash Flow

Operating Cash Flow TTM $170,718,000
Levered Free Cash Flow TTM $117,813,128

ANIP Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 22,462,035
Float Shares 18,895,277
Avg 10 Volume 453,286
Avg 30 Volume None
Shares Short 2,668,488
Short Ratio 6.13
Short % of Shares 14.80%
% Held by Insiders 9.99%
% Held by Institutions 97.83%

Stock Price Summary

Beta 0.48
Fifty Two Week Low $52.74
Fifty Two Week High $99.50
Fifty Two Week Change 30.38%
Day 50 MA $85.34
Day 200 MA $77.28

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date 2013-07-18